We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$611M
AUM Growth
+$61.5M
Cap. Flow
+$1.51M
Cap. Flow %
0.25%
Top 10 Hldgs %
8.42%
Holding
675
New
112
Increased
203
Reduced
170
Closed
94

Top Buys

Rank Stock Value
1
CVX icon
Chevron
CVX
+$3.54M
2
ALGN icon
Align Technology
ALGN
+$2.35M
3
HAL icon
Halliburton
HAL
+$2.04M
4
LYB icon
LyondellBasell Industries
LYB
+$2M
5
AVGO icon
Broadcom
AVGO
+$1.88M

Top Sells

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.79M
2
KMI icon
Kinder Morgan
KMI
+$2.84M
3
DIS icon
Walt Disney
DIS
+$2.64M
4
VMW
VMware, Inc
VMW
+$2.56M
5
PFE icon
Pfizer
PFE
+$2.49M

Sector Composition

Rank Sector Weight
1 Technology 18.17%
2 Financials 18.09%
3 Healthcare 13.8%
4 Industrials 13.04%
5 Consumer Discretionary 9.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BLDR icon
501
Builders FirstSource
BLDR
$7.74B
$254K 0.04%
+1,524
New +$203K
RLAY icon
502
Relay Therapeutics
RLAY
$4.37B
$254K 0.04%
23,088
CBOE icon
503
Cboe Global Markets
CBOE
$29.8B
$250K 0.04%
1,402
FICO icon
504
Fair Isaac
FICO
$22.7B
$249K 0.04%
+214
New +$215K
RARE icon
505
Ultragenyx Pharmaceutical
RARE
$2.64B
$246K 0.04%
+5,146
New +$199K
ADP icon
506
Automatic Data Processing
ADP
$109B
$245K 0.04%
1,052
DHI icon
507
D.R. Horton
DHI
$41B
$245K 0.04%
+1,612
New +$198K
RCUS icon
508
Arcus Biosciences
RCUS
$3.66B
$244K 0.04%
12,787
SBUX icon
509
Starbucks
SBUX
$119B
$242K 0.04%
2,521
EVR icon
510
Evercore
EVR
$11.5B
$241K 0.04%
+1,409
New +$204K
SAGE
511
DELISTED
Sage Therapeutics
SAGE
$239K 0.04%
11,048
-18
-0.2% -$357
HPE icon
512
Hewlett Packard
HPE
$72.4B
$234K 0.04%
13,791
-165
-1% -$2.69K
ROL icon
513
Rollins
ROL
$17.9B
$233K 0.04%
5,335
-125
-2% -$4.87K
AEE icon
514
Ameren
AEE
$29.6B
$233K 0.04%
3,220
-29,537
-90% -$2.25M
BDTX icon
515
Black Diamond Therapeutics
BDTX
$114M
$233K 0.04%
+82,784
New +$194K
MGTX icon
516
MeiraGTx Holdings
MGTX
$1.21B
$225K 0.04%
32,083
+217
+0.7% +$1.07K
CPRX
517
DELISTED
Catalyst Pharmaceutical
CPRX
$225K 0.04%
13,387
-73,786
-85% -$1.01M
REPL icon
518
Replimune Group
REPL
$1.15B
$223K 0.04%
+26,493
New +$307K
FANG icon
519
Diamondback Energy
FANG
$55.7B
$221K 0.04%
1,424
BLD
520
DELISTED
TopBuild
BLD
$221K 0.04%
+590
New +$169K
LOW icon
521
Lowe's Companies
LOW
$123B
$219K 0.04%
982
ALDX icon
522
Aldeyra Therapeutics
ALDX
$91.1M
$216K 0.04%
+61,601
New +$190K
DIS icon
523
Walt Disney
DIS
$178B
$216K 0.04%
2,394
-29,962
-93% -$2.64M
DECK icon
524
Deckers Outdoor
DECK
$13.3B
$214K 0.04%
+1,920
New +$195K
RGNX icon
525
Regenxbio
RGNX
$688M
$214K 0.04%
11,902
-19
-0.2% -$335

Similar funds

Cornercap Investment Counsel's Q4 2023 Portfolio in Review

As of Q4 2023, Cornercap Investment Counsel held 675 positions worth $611M, up 11% from $550M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

Cornercap Investment Counsel's Q4 2023 filing shows 112 new, 203 increased, 170 reduced and 94 closed positions. Its largest new stake was Align Technology: 9,904 shares worth $2.71M. The largest sale was ExxonMobil, an estimated $5.79M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Cornercap Investment Counsel's largest Q4 2023 buy was Align Technology: 9,904 shares worth $2.71M.
  • Cornercap Investment Counsel added most to Chevron in Q4 2023, an estimated $3.54M increase.
  • Cornercap Investment Counsel's biggest Q4 2023 reduction was ExxonMobil, cutting an estimated $5.79M.
  • Cornercap Investment Counsel fully exited VMware, Inc in Q4 2023, selling an estimated $2.56M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.4% of its $611M portfolio in Q4 2023.
  • Cornercap Investment Counsel opened 112 new positions and closed 94 in Q4 2023.
  • Cornercap Investment Counsel's portfolio value rose 11% quarter-over-quarter to $611M.

Based on Cornercap Investment Counsel's 13F filing for Q4 2023, filed 30 Jan 2024.